CIK 0001831828
- Large accelerated filer
Vera Therapeutics, Inc.
Sign in to watch- Ticker
- VERA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812744449
- Phone
- +1 650-770-0077
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE, CA, 94005
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,334,142
- in 2 filings, $1.3M under 10b5-1 plans
Net −$1,334,142. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-06 | Young Joseph R SVP, Finance, Chief Acct Offcr | Purchase | +5,714 | $7.00 | $40K | 22,679 |
| 2022-02-06 | Grant Sean Chief Financial Officer | Purchase | +14,285 | $7.00 | $100K | 49,933 |
| 2021-12-10 | Hall Kimball Director | Grant or award · Stock Option (right to buy) | +19,850 | 19,850 | ||
| 2021-07-13 | Grant Sean Chief Financial Officer | Grant or award · Stock Option (right to buy) | +180,000 | 180,000 | ||
| 2021-05-18 | Sofinnova Venture Partners X, L.P. 10% owner | Conversion | +2,187,504 | 2,187,504 | ||
| 2021-05-18 | Sofinnova Venture Partners X, L.P. 10% owner | Purchase | +727,272 | $11.00 | $8.0M | 2,914,776 |
| 2021-05-18 | Sofinnova Venture Partners X, L.P. 10% owner | Conversion · Series C Preferred Stock | −2,187,504 | 0 | ||
| 2021-05-18 | Longitude Capital Partners IV, LLC 10% owner | Conversion | +2,187,504 | 2,187,504 | ||
| 2021-05-18 | Longitude Capital Partners IV, LLC 10% owner | Purchase | +909,090 | $11.00 | $10.0M | 3,096,594 |
| 2021-05-18 | Longitude Capital Partners IV, LLC 10% owner | Conversion · Series C Preferred Stock | −2,187,504 | 0 | ||
| 2021-05-18 | Katabi Maha Director | Conversion | +2,187,504 | 2,187,504 | ||
| 2021-05-18 | Katabi Maha Director | Purchase | +727,272 | $11.00 | $8.0M | 2,914,776 |
| 2021-05-18 | Katabi Maha Director | Conversion · Series C Preferred Stock | −2,187,504 | 0 | ||
| 2021-05-18 | SEIDENBERG BETH C Director | Conversion | +423,642 | 423,642 | ||
| 2021-05-18 | SEIDENBERG BETH C Director | Conversion | +100,526 | 524,168 | ||
| 2021-05-18 | SEIDENBERG BETH C Director | Conversion | +818,984 | 1,343,152 | ||
| 2021-05-18 | SEIDENBERG BETH C Director | Conversion · Series A Preferred Stock | −423,642 | 0 | ||
| 2021-05-18 | SEIDENBERG BETH C Director | Conversion · Series B Preferred Stock | −100,526 | 0 | ||
| 2021-05-18 | SEIDENBERG BETH C Director | Conversion · Series C Preferred Stock | −818,984 | 0 | ||
| 2021-05-18 | ENRIGHT PATRICK G Director | Conversion | +2,187,504 | 2,187,504 |
Page 28 of 30 · 581 trades